OBJECTIVE: To perform a comparative analysis of infiltrating immune cells in a newly developed C57BL/6 background syngeneic transplantable mouse oral cancer (MOC) model. STUDY DESIGN/ SETTING: Scientific study in an academic medical center. METHODS: Use of carcinogen-induced tumorigenesis, tissue culture, cell line transplantation, and flow cytometric analysis techniques. RESULTS: Previously, the authors established a series of cell line models that displayed dichotomous growth phenotypes when transplanted into immunocompetent mice. They now show that the indolent growth pattern of the MOC1-generated tumors is associated with increased baseline and inducible major histocompatibility complex class I expression and increased CD8(+) T-cell infiltration into the tumor microenvironment. Conversely, the aggressive and metastatic pattern of MOC2-generated tumors has decreased basal and inducible class I expression and is associated with FOXP3(+)CD4(+) regulatory T-cell infiltration. Delayed primary tumor growth after targeted monoclonal antibody therapy of these FOXP3(+) regulatory cells further suggests that these immune cells contribute to the aggressive phenotype of MOC2. CONCLUSION: These data validate that key infiltrating immune cells identified here parallel findings in human head and neck cancer, making this newly developed syngeneic model a critical platform for the continued dissection of tumor-host interactions in head and neck cancer.
OBJECTIVE: To perform a comparative analysis of infiltrating immune cells in a newly developed C57BL/6 background syngeneic transplantable mouseoral cancer (MOC) model. STUDY DESIGN/ SETTING: Scientific study in an academic medical center. METHODS: Use of carcinogen-induced tumorigenesis, tissue culture, cell line transplantation, and flow cytometric analysis techniques. RESULTS: Previously, the authors established a series of cell line models that displayed dichotomous growth phenotypes when transplanted into immunocompetent mice. They now show that the indolent growth pattern of the MOC1-generated tumors is associated with increased baseline and inducible major histocompatibility complex class I expression and increased CD8(+) T-cell infiltration into the tumor microenvironment. Conversely, the aggressive and metastatic pattern of MOC2-generated tumors has decreased basal and inducible class I expression and is associated with FOXP3(+)CD4(+) regulatory T-cell infiltration. Delayed primary tumor growth after targeted monoclonal antibody therapy of these FOXP3(+) regulatory cells further suggests that these immune cells contribute to the aggressive phenotype of MOC2. CONCLUSION: These data validate that key infiltrating immune cells identified here parallel findings in human head and neck cancer, making this newly developed syngeneic model a critical platform for the continued dissection of tumor-host interactions in head and neck cancer.
Authors: Sayuri Miyauchi; P Dominick Sanders; Kripa Guram; Sangwoo S Kim; Francesca Paolini; Aldo Venuti; Ezra E W Cohen; J Silvio Gutkind; Joseph A Califano; Andrew B Sharabi Journal: Cancer Res Date: 2019-12-17 Impact factor: 12.701
Authors: Neeraja Dharmaraj; Stacey L Piotrowski; Chen Huang; Jared M Newton; Leonard S Golfman; Aurelie Hanoteau; Sandeep T Koshy; Aileen W Li; Merlyn X Pulikkathara; Bing Zhang; Jared K Burks; David J Mooney; Yu L Lei; Andrew G Sikora; Simon Young Journal: Oncoimmunology Date: 2019-02-06 Impact factor: 8.110
Authors: Ayman Oweida; Mohammad K Hararah; Andy Phan; David Binder; Shilpa Bhatia; Shelby Lennon; Sanjana Bukkapatnam; Benjamin Van Court; Nomin Uyanga; Laurel Darragh; Hyun Min Kim; David Raben; Aik Choon Tan; Lynn Heasley; Eric Clambey; Raphael Nemenoff; Sana D Karam Journal: Clin Cancer Res Date: 2018-07-24 Impact factor: 12.531
Authors: Ellen C Moore; Harrison A Cash; Andria M Caruso; Ravindra Uppaluri; James W Hodge; Carter Van Waes; Clint T Allen Journal: Cancer Immunol Res Date: 2016-04-13 Impact factor: 11.151
Authors: Dhanya K Nambiar; Todd Aguilera; Hongbin Cao; Shirley Kwok; Christina Kong; Joshua Bloomstein; Zemin Wang; Vangipuram S Rangan; Dadi Jiang; Rie von Eyben; Rachel Liang; Sonya Agarwal; A Dimitrios Colevas; Alan Korman; Clint T Allen; Ravindra Uppaluri; Albert C Koong; Amato Giaccia; Quynh Thu Le Journal: J Clin Invest Date: 2019-12-02 Impact factor: 14.808
Authors: Lucas T Woods; Kimberly J Jasmer; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Laurie Erb; Michael J Petris; Gary A Weisman Journal: Oral Oncol Date: 2020-06-12 Impact factor: 5.337
Authors: David G Leach; Neeraja Dharmaraj; Tania L Lopez-Silva; Jose Rodriguez Venzor; Brett H Pogostin; Andrew G Sikora; Jeffrey D Hartgerink; Simon Young Journal: ACS Biomater Sci Eng Date: 2021-01-20